Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1832588 (PSS)
 2,979 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Transurethral laser adenomectomy was performed in 37 patients with benign prostatic hyperplasia (BPH) aged 49-73 years (mean age 68 years) under epidural anesthesia. The intervention lasted 35-90 minutes (mean--55 minutes). Ho-YAG-laser was used (Versa Pulse, Coherent; 80 W, impulse regime, 2.09 microm, 50-100 Hz). 32 patients had intercurrent diseases (essential hypertension, diabetes mellitus, etc.). If the procedure technique was not violated, the postoperative period ran uneventfully. Coagulative effect of Ho-laser minimizes blood loss. Foley catheter was inserted. 12-24-h continuous irrigation of the urinary bladder was carried out. The drainage of the bladder with urethral catheter took 1-3 days. All the patients were discharged from hospital on postoperative day 5-7. Their condition was satisfactory. The patients were followed up for 8 months. Positive changes in urodynamics were recorded: I-PSS dropped from 21.4 to 11.2, maximal urine flow rate increased from 7.3 to 20.2 ml/s. Residual urine volume diminished to 0-30 ml compared to 190 ml before the operation. Secondary bleeding was absent. Minimal traumaticity and minimal blood loss allow to recommend laser adenomectomy both for BPH with and without intercurrent diseases.
 ...
PMID:[Holmium laser treatment of benign prostatic hyperplasia]. 1114 30